111 related articles for article (PubMed ID: 35021784)
1. Intelligent Size-Changeable Nanoparticles for Enhanced Tumor Accumulation and Deep Penetration.
Yu W; Hu C; Gao H
ACS Appl Bio Mater; 2020 Sep; 3(9):5455-5462. PubMed ID: 35021784
[TBL] [Abstract][Full Text] [Related]
2. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy.
Li J; Wang Y; Xu C; Yu Q; Wang X; Xie H; Tian L; Qiu Y; Guo R; Lu Z; Li M; He Q
Acta Biomater; 2021 Oct; 134():546-558. PubMed ID: 33882357
[TBL] [Abstract][Full Text] [Related]
3. pH-Responsive size-shrinkable mesoporous silica-based nanocarriers for improving tumor penetration and therapeutic efficacy.
He Y; Fan X; Wu X; Hu T; Zhou F; Tan S; Chen B; Pan A; Liang S; Xu H
Nanoscale; 2022 Jan; 14(4):1271-1284. PubMed ID: 35006226
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy.
Hu C; Cun X; Ruan S; Liu R; Xiao W; Yang X; Yang Y; Yang C; Gao H
Biomaterials; 2018 Jun; 168():64-75. PubMed ID: 29626787
[TBL] [Abstract][Full Text] [Related]
5. Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles.
Niu Y; Zhu J; Li Y; Shi H; Gong Y; Li R; Huo Q; Ma T; Liu Y
J Control Release; 2018 May; 277():35-47. PubMed ID: 29545106
[TBL] [Abstract][Full Text] [Related]
6. Size-Tunable Strategies for a Tumor Targeted Drug Delivery System.
Yu W; Liu R; Zhou Y; Gao H
ACS Cent Sci; 2020 Feb; 6(2):100-116. PubMed ID: 32123729
[TBL] [Abstract][Full Text] [Related]
7. A Novel Strategy through Combining iRGD Peptide with Tumor-Microenvironment-Responsive and Multistage Nanoparticles for Deep Tumor Penetration.
Cun X; Chen J; Ruan S; Zhang L; Wan J; He Q; Gao H
ACS Appl Mater Interfaces; 2015 Dec; 7(49):27458-66. PubMed ID: 26633260
[TBL] [Abstract][Full Text] [Related]
8. [The development of novel tumor targeting delivery strategy].
Gao HL; Jiang XG
Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
[TBL] [Abstract][Full Text] [Related]
9. Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy.
Xie Z; Guo W; Guo N; Huangfu M; Liu H; Lin M; Xu W; Chen J; Wang T; Wei Q; Han M; Gao J
Acta Biomater; 2018 Apr; 71():351-362. PubMed ID: 29545193
[TBL] [Abstract][Full Text] [Related]
10. Tumor-Microenvironment- Responsive Size-Shrinkable Drug-Delivery Nanosystems for Deepened Penetration Into Tumors.
Cheng X; Li H; Ge X; Chen L; Liu Y; Mao W; Zhao B; Yuan WE
Front Mol Biosci; 2020; 7():576420. PubMed ID: 33330618
[TBL] [Abstract][Full Text] [Related]
11. Facile fabrication of multi-pocket nanoparticles with stepwise size transition for promoting deep penetration and tumor targeting.
Hou X; Zhong D; Li Y; Mao H; Yang J; Zhang H; Luo K; Gong Q; Gu Z
J Nanobiotechnology; 2021 Apr; 19(1):111. PubMed ID: 33874945
[TBL] [Abstract][Full Text] [Related]
12. MMP-2-Sensitive HA End-Conjugated Poly(amidoamine) Dendrimers via Click Reaction To Enhance Drug Penetration into Solid Tumor.
Han M; Huang-Fu MY; Guo WW; Guo NN; Chen J; Liu HN; Xie ZQ; Lin MT; Wei QC; Gao JQ
ACS Appl Mater Interfaces; 2017 Dec; 9(49):42459-42470. PubMed ID: 29143522
[TBL] [Abstract][Full Text] [Related]
13. Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration.
Son S; Deepagan VG; Shin S; Ko H; Min J; Um W; Jeon J; Kwon S; Lee ES; Suh M; Lee DS; Park JH
Acta Biomater; 2018 Oct; 79():294-305. PubMed ID: 30134209
[TBL] [Abstract][Full Text] [Related]
14. Furin-responsive triterpenine-based liposomal complex enhances anticervical cancer therapy through size modulation.
Chen Y; Guo M; Qu D; Liu Y; Guo J; Chen Y
Drug Deliv; 2020 Dec; 27(1):1608-1624. PubMed ID: 33179521
[TBL] [Abstract][Full Text] [Related]
15. A Near-Infrared Laser-Triggered Size-Shrinkable Nanosystem with In Situ Drug Release for Deep Tumor Penetration.
Wu D; Xu S; Zhang X; Li Y; Zhang W; Yan Q; Yang Q; Guo F; Yang G
ACS Appl Mater Interfaces; 2021 Apr; 13(14):16036-16047. PubMed ID: 33733732
[TBL] [Abstract][Full Text] [Related]
16. Small Morph Nanoparticles for Deep Tumor Penetration via Caveolae-Mediated Transcytosis.
Zhang Z; Wang T; Yang R; Fu S; Guan L; Hou T; Mu W; Pang X; Liang S; Liu Y; Zhang N
ACS Appl Mater Interfaces; 2020 Aug; 12(34):38499-38511. PubMed ID: 32805954
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release.
Ruan S; Cao X; Cun X; Hu G; Zhou Y; Zhang Y; Lu L; He Q; Gao H
Biomaterials; 2015 Aug; 60():100-10. PubMed ID: 25988725
[TBL] [Abstract][Full Text] [Related]
18. Structure-Switchable DNA Programmed Disassembly of Nanoparticles for Smart Size Tunability and Cancer-Specific Drug Release.
Ye W; Chen X; Li X; Liu Y; Jia F; Jin Q; Ji J
ACS Appl Mater Interfaces; 2020 May; 12(20):22560-22571. PubMed ID: 32338490
[TBL] [Abstract][Full Text] [Related]
19. NIR II-Excited and pH-Responsive Ultrasmall Nanoplatform for Deep Optical Tissue and Drug Delivery Penetration and Effective Cancer Chemophototherapy.
Zhu L; Gao D; Xie L; Dai Y; Zhao Q
Mol Pharm; 2020 Oct; 17(10):3720-3729. PubMed ID: 32633977
[TBL] [Abstract][Full Text] [Related]
20. Tumor microenvironment-activated therapeutic peptide-conjugated prodrug nanoparticles for enhanced tumor penetration and local T cell activation in the tumor microenvironment.
Zhu X; Li C; Lu Y; Liu Y; Wan D; Zhu D; Pan J; Ma G
Acta Biomater; 2021 Jan; 119():337-348. PubMed ID: 33166712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
